GSK1511931   Click here for help

GtoPdb Ligand ID: 8644

Synonyms: compound 14 [PMID: 19081716] | GSK-1511931 | GSK1511931A
Compound class: Synthetic organic
Comment: GSK1511931 is an investigational IGF-1R inhibitor [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 94.23
Molecular weight 508.27
XLogP 5.36
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1cc(ccc1Nc1nc(Nc2cccc3c2cccn3)c2c(n1)[nH]cc2)N1CCN(CC1)C(C)C
Isomeric SMILES COc1cc(ccc1Nc1nc(Nc2cccc3c2cccn3)c2c(n1)[nH]cc2)N1CCN(CC1)C(C)C
InChI InChI=1S/C29H32N8O/c1-19(2)36-14-16-37(17-15-36)20-9-10-25(26(18-20)38-3)33-29-34-27-22(11-13-31-27)28(35-29)32-24-8-4-7-23-21(24)6-5-12-30-23/h4-13,18-19H,14-17H2,1-3H3,(H3,31,32,33,34,35)
InChI Key PEPOAPKYASCEKL-UHFFFAOYSA-N
Bioactivity Comments
Suggested additional kinase targets are GAK (cyclin G associated kinase; involved in centrosome maturation), STK33 (interacts with oncogenoc KRAS) and TTK (associated with breast cancer).
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
Insulin-like growth factor I receptor Hs Inhibitor Inhibition 6.6 pIC50 - 1
pIC50 6.6 (IC50 2.5x10-7 M) [1]